Michael J. Tokar

Array ( [id] => 8522673 [patent_doc_number] => 20120322081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-20 [patent_title] => 'METHODS FOR DETECTION OF BOTULINUM NEUROTOXIN' [patent_app_type] => utility [patent_app_number] => 13/306769 [patent_app_country] => US [patent_app_date] => 2011-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 13272 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13306769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9227120 [patent_doc_number] => 08632786 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-21 [patent_title] => 'Dose and localization of botulinum toxins in skin and muscle' [patent_app_type] => utility [patent_app_number] => 13/373395 [patent_app_country] => US [patent_app_date] => 2011-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 3632 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13373395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8772234 [patent_doc_number] => 08426187 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-23 [patent_title] => 'Immunoglobulin libraries' [patent_app_type] => utility [patent_app_number] => 13/288767 [patent_app_country] => US [patent_app_date] => 2011-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 33305 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13288767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8278485 [patent_doc_number] => 20120172356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'SERUM BIOMARKERS FOR CHAGAS DISEASE' [patent_app_type] => utility [patent_app_number] => 13/280830 [patent_app_country] => US [patent_app_date] => 2011-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 24336 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13280830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9093781 [patent_doc_number] => 20130273092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-17 [patent_title] => 'USES OF YERSINIA YOPE PEPTIDE, GENE AND SUBPARTS THEREOF AS A PLAGUE VACCINE COMPONENT AND ASSAYS FOR YERSINIA PESTIS-SPECIFIC T CELLS' [patent_app_type] => utility [patent_app_number] => 13/879334 [patent_app_country] => US [patent_app_date] => 2011-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12658 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13879334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9698669 [patent_doc_number] => 20140248354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-04 [patent_title] => 'CONTROLLED RELEASE VACCINES AND METHODS FOR TREATING BRUCELLA DISEASES AND DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/269382 [patent_app_country] => US [patent_app_date] => 2011-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 20097 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13269382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9191053 [patent_doc_number] => 20130330369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'Reduction Of Antibody Response Against Botulinum Neurotoxin And Variants Thereof' [patent_app_type] => utility [patent_app_number] => 13/878288 [patent_app_country] => US [patent_app_date] => 2011-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5478 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13878288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7742353 [patent_doc_number] => 20120021002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'GENETICALLY ENGINEERED CLOSTRIDIAL GENES, PROTEINS ENCODED BY THE ENGINEERED GENES, AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/252177 [patent_app_country] => US [patent_app_date] => 2011-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 29852 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20120021002.pdf [firstpage_image] =>[orig_patent_app_number] => 13252177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9094261 [patent_doc_number] => 20130273572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-17 [patent_title] => 'Methods for Diagnosing Lyme Disease' [patent_app_type] => utility [patent_app_number] => 13/876077 [patent_app_country] => US [patent_app_date] => 2011-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13224 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13876077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9033851 [patent_doc_number] => 20130236489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-12 [patent_title] => 'DEVELOPMENTS IN MENINGOCOCCAL OUTER MEMBRANE VESICLES' [patent_app_type] => utility [patent_app_number] => 13/822238 [patent_app_country] => US [patent_app_date] => 2011-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13169 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13822238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586391 [patent_doc_number] => 20110280901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'Diagnosis and treatment of Trypanosoma cruzi infection and chagas disease' [patent_app_type] => utility [patent_app_number] => 13/135621 [patent_app_country] => US [patent_app_date] => 2011-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11353 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280901.pdf [firstpage_image] =>[orig_patent_app_number] => 13135621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9831670 [patent_doc_number] => 08940482 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-01-27 [patent_title] => 'N-end rule protease activity indication methods and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/159284 [patent_app_country] => US [patent_app_date] => 2011-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6376 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13159284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6088082 [patent_doc_number] => 20110217366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'IMMUNOPOTENTIATING COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/109949 [patent_app_country] => US [patent_app_date] => 2011-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16079 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217366.pdf [firstpage_image] =>[orig_patent_app_number] => 13109949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10006789 [patent_doc_number] => 09050285 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-09 [patent_title] => 'Recombinant bacterium capable of eliciting an immune response against Streptococcus pneumoniae' [patent_app_type] => utility [patent_app_number] => 13/088141 [patent_app_country] => US [patent_app_date] => 2011-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 152 [patent_figures_cnt] => 179 [patent_no_of_words] => 40304 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 385 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13088141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8363484 [patent_doc_number] => 08252550 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-28 [patent_title] => 'Targeting poly-γ-glutamic acid to treat Staphylococcus epidermidis and related infections' [patent_app_type] => utility [patent_app_number] => 13/035716 [patent_app_country] => US [patent_app_date] => 2011-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 13 [patent_no_of_words] => 20773 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13035716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8277318 [patent_doc_number] => 20120171193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'Diagnostic and Treatment Methods for Characterizing Bacterial Microbiota in Skin Conditions' [patent_app_type] => utility [patent_app_number] => 13/034359 [patent_app_country] => US [patent_app_date] => 2011-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15742 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13034359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8660312 [patent_doc_number] => 20130041140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'Preparation and/or Purification of Oligonucleotide Conjugates' [patent_app_type] => utility [patent_app_number] => 13/578752 [patent_app_country] => US [patent_app_date] => 2011-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 23988 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13578752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6164954 [patent_doc_number] => 20110195086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => '15-VALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE VACCINE COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/020402 [patent_app_country] => US [patent_app_date] => 2011-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10778 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195086.pdf [firstpage_image] =>[orig_patent_app_number] => 13020402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936036 [patent_doc_number] => 20110212133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'Novel Methods of Diagnosis and Treatment of P. Aeruginosa Infection and Reagents Therefor' [patent_app_type] => utility [patent_app_number] => 13/020639 [patent_app_country] => US [patent_app_date] => 2011-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22373 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212133.pdf [firstpage_image] =>[orig_patent_app_number] => 13020639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9823117 [patent_doc_number] => 08932600 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-13 [patent_title] => 'Modified tuberculosis antigens' [patent_app_type] => utility [patent_app_number] => 13/574816 [patent_app_country] => US [patent_app_date] => 2011-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 44848 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13574816 [rel_patent_id] =>[rel_patent_doc_number] =>)